Try Gyn: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Try Gyn
Largest movements
- Tangible fixed assets -€12,959
down €12,959 (-47.2%), from €27,429 to €14,470
- Receivables within one year +€5,260
up €5,260 (+71.8%), from €7,327 to €12,587
- Profit (loss) carried forward -€6,880
down €6,880 (-53.7%), from €12,808 to €5,929
- Gross operating margin -€11,334
down €11,334 (-5.1%), from €223,382 to €212,048
- Taxes -€2,939
down €2,939 (-6.1%), from €47,824 to €44,885
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €205,542 | €198,367 | -€7,175 | -3.5% |
| Fixed assets | 21/28 | €27,429 | €14,470 | -€12,959 | -47.2% |
| Tangible fixed assets | 22/27 | €27,429 | €14,470 | -€12,959 | -47.2% |
| Furniture and vehicles | 24 | €27,429 | €14,470 | -€12,959 | -47.2% |
| Current assets | 29/58 | €178,113 | €183,897 | +€5,783 | +3.2% |
| Amounts receivable within one year | 40/41 | €7,327 | €12,587 | +€5,260 | +71.8% |
| Other amounts receivable | 41 | €7,327 | €12,587 | +€5,260 | +71.8% |
| Cash at bank and in hand | 54/58 | €168,094 | €168,707 | +€613 | +0.4% |
| Deferred charges and accrued income | 490/1 | €2,692 | €2,602 | -€90 | -3.3% |
| Total equity and liabilities | 10/49 | €205,542 | €198,367 | -€7,175 | -3.5% |
| Equity | 10/15 | €33,268 | €26,389 | -€6,880 | -20.7% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €12,808 | €5,929 | -€6,880 | -53.7% |
| Amounts payable | 17/49 | €172,273 | €171,978 | -€296 | -0.2% |
| Amounts payable within one year | 42/48 | €172,273 | €171,978 | -€296 | -0.2% |
| Trade debts | 44 | €338 | €130 | -€208 | -61.4% |
| Suppliers | 440/4 | €338 | €130 | -€208 | -61.4% |
| Taxes, remuneration and social security | 45 | €5,700 | €5,650 | -€50 | -0.9% |
| Taxes | 450/3 | €3,375 | €3,375 | = | 0.0% |
| Remuneration and social security | 454/9 | €2,325 | €2,275 | -€50 | -2.2% |
| Other amounts payable | 47/48 | €166,236 | €166,198 | -€38 | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €13,790 | €13,940 | +€149 | +1.1% |
| Other operating charges | 640/8 | €288 | €297 | +€9 | +3.0% |
| Gross operating margin | 9900 | €223,382 | €212,048 | -€11,334 | -5.1% |
| Operating profit (loss) | 9901 | €209,304 | €197,812 | -€11,492 | -5.5% |
| Financial income | 75/76B | €503 | €483 | -€20 | -4.0% |
| Recurring financial income | 75 | €503 | €483 | -€20 | -4.0% |
| Financial charges | 65/66B | €323 | €290 | -€33 | -10.2% |
| Recurring financial charges | 65 | €323 | €290 | -€33 | -10.2% |
| Profit (loss) for the period before taxes | 9903 | €209,484 | €198,005 | -€11,479 | -5.5% |
| Income taxes | 67/77 | €47,824 | €44,885 | -€2,939 | -6.1% |
| Profit (loss) for the period | 9904 | €161,660 | €153,120 | -€8,540 | -5.3% |
| Profit (loss) for the period to be appropriated | 9905 | €161,660 | €153,120 | -€8,540 | -5.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.